BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 9440541)

  • 21. Mast cells with bilobed or multilobed nuclei in a nodular lesion of a patient with urticaria pigmentosa.
    Hu S; Kuo TT; Hong HS
    Am J Dermatopathol; 2002 Dec; 24(6):490-2. PubMed ID: 12454601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of tryptase- and chymase-containing mast cells in cutaneous lichen planus.
    Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M
    Acta Derm Venereol; 1991; 71(5):394-8. PubMed ID: 1721758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
    Florian S; Krauth MT; Simonitsch-Klupp I; Sperr WR; Fritsche-Polanz R; Sonneck K; Födinger M; Agis H; Böhm A; Wimazal F; Horny HP; Valent P
    Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mastocytosis: new understandings in cutaneous pathophysiology.
    Lazarus GS
    J Dermatol; 1996 Nov; 23(11):769-72. PubMed ID: 8990699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers of mast cell degranulation.
    Hogan AD; Schwartz LB
    Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basophil/mast cell precursors in mast cell proliferative disorders.
    Denburg JA; Telizyn S; Ahlstedt S; Olafsson JH; Roupe G; Bienenstock J
    Clin Invest Med; 1986; 9(1):21-5. PubMed ID: 3955917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mastocytosis with urticaria pigmentosa and osteoporosis.
    Stein JA; Kamino H; Walters RF; Pomeranz MK
    Dermatol Online J; 2008 Oct; 14(10):2. PubMed ID: 19061601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal mucosal mast cells: enumeration in urticaria pigmentosa and systemic mastocytosis.
    Ferguson J; Thompson RP; Greaves MW
    Br J Dermatol; 1988 Nov; 119(5):573-8. PubMed ID: 3207611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous mastocytosis in Singapore.
    Tay YK; Giam YC
    Singapore Med J; 1993 Oct; 34(5):425-9. PubMed ID: 8153691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation.
    He S; Walls AF
    Eur J Pharmacol; 1997 Jun; 328(1):89-97. PubMed ID: 9203574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.
    Theoharides TC; Boucher W; Spear K
    Int Arch Allergy Immunol; 2002 Aug; 128(4):344-50. PubMed ID: 12218373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
    Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
    Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
    Siegert SI; Diebold J; Ludolph-Hauser D; Löhrs U
    Am J Clin Pathol; 2004 Oct; 122(4):560-5. PubMed ID: 15487454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-localization of tryptase and cathepsin-G in mast cells in cutaneous mastocytosis.
    Ribatti D; Nico B; Finato N; Crivellato E; Beltrami CA
    Cancer Lett; 2009 Jul; 279(2):209-12. PubMed ID: 19250736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of immunostaining for tryptase in patients with mastocytosis.
    Horny HP; Sillaber C; Menke D; Kaiserling E; Wehrmann M; Stehberger B; Chott A; Lechner K; Lennert K; Valent P
    Am J Surg Pathol; 1998 Sep; 22(9):1132-40. PubMed ID: 9737247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The skin in mastocytosis.
    Soter NA
    J Invest Dermatol; 1991 Mar; 96(3 Suppl):32S-38S; discussion 38S-39S, 60S-65S. PubMed ID: 16799606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes.
    Graves L; Stechschulte DJ; Morris DC; Lukert BP
    J Bone Miner Res; 1990 Nov; 5(11):1113-9. PubMed ID: 2270775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of p16(INK4a) in Mastocytosis (Urticarial Pigmentosa).
    Tsujita J; Doi K; Nakahara M; Nakahara T; Kaku Y; Nishio K; Kan N; Sato Y; Nagata S; Nakao A; Yoshida M; Uchi H; Furue M
    Fukuoka Igaku Zasshi; 2016 Jan; 107(1):12-7. PubMed ID: 27333655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mastocytosis in children: a single-center long-term follow-up study.
    Popadic S; Lalosevic J; Lekic B; Gajić-Veljic M; Bonaci-Nikolic B; Nikolic M
    Int J Dermatol; 2023 May; 62(5):616-620. PubMed ID: 36807903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells.
    Kivinen PK; Kaminska R; Naukkarinen A; Harvima RJ; Horsmanheimo M; Harvima IT
    Exp Dermatol; 2001 Aug; 10(4):246-55. PubMed ID: 11493313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.